$BPTH skyrockets on Received Third U.S. Patent Grant

10 ก.พ. 2021

Bio-Path Receives Third U.S. Patent Grant Related to Manufacture of Platform Technology

Provides Expanded Protection to Seminal Patents Related to DNAbilize

The new patent builds on earlier patents granted that protect the platform technology for DNAbilize®, the Company’s novel RNAi nanoparticle drugs.


finance.yahoo.com/news/bio-path-receives-third-u-120000403.html